Tsukuba, Japan

Jun Aruga

This inventor holds 3 USPTO granted patents. Top assignee: The Institute of Physical and Chemical Research. Active years: 2001-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jun Aruga. Retrieved from https://idiyas.com/inventor/jun-aruga

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 66.7

Average Co-Inventor Count = 4.0

ph-index = 1


Location History:

  • Ibaraki, JP (2001)
  • Tsukuba, JP (2002 - 2005)

Company Filing History:


Years Active: 2001-2005

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jun Aruga: Innovator in Neurogenesis Research

Introduction

Jun Aruga is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of neurogenesis, focusing on the development of therapeutic agents for nervous diseases. With a total of 3 patents, Aruga's work is paving the way for advancements in gene therapy.

Latest Patents

One of Aruga's latest patents involves neurogenesis inducing genes. This invention relates specifically to genes coding for Zic proteins. The patent provides vectors containing these genes, host cells that incorporate such vectors, and proteins produced by these host cells. Additionally, it includes antibodies raised against these proteins and therapeutic agents for gene therapy targeting nervous diseases.

Career Highlights

Aruga is affiliated with the Institute of Physical and Chemical Research, where he conducts his innovative research. His work has garnered attention for its potential impact on treating neurological disorders.

Collaborations

Aruga collaborates with notable colleagues, including Katsuhiko Mikoshiba and Takeharu Nagai. Their combined expertise enhances the research efforts in neurogenesis and gene therapy.

Conclusion

Jun Aruga's contributions to neurogenesis research and gene therapy are noteworthy. His innovative patents and collaborations position him as a key figure in advancing treatments for nervous diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…